Physician profile
Thomas E Velling
NPI 1689618209
$9,034.66
in general payments reported to CMS, 2019-2025
29 companies · $928 in 2025
The $928 reported for 2025 was more than what 84% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $854 · 2020: $3,454 · 2021: $899 · 2022: $1,258 · 2023: $1,196 · 2024: $445 · 2025: $928.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,569.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microvention, INC. | $2,993.66 | 2019-2025 | Eric Retrieval Device, Chaperon Guiding Catheter, Sofia 6f-131cm Str |
| Boston Scientific Corporation | $1,150.36 | 2019-2025 | Embold Fibered, Therasphere360_pi, Lux-Dx Insertable Cardiac Monitor |
| Inari Medical, INC. | $788.24 | 2019-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Stryker Corporation | $664.98 | 2019-2025 | Flowtriever, Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $614.23 | 2021-2024 | Kyphon Express II Kyphopak Tray, Concertotm |
| Sirtex Medical INC | $493.95 | 2023-2025 | Sir-Spheres Microspheres |
| Penumbra, INC. | $330.49 | 2020-2021 | |
| Bard Peripheral Vascular, INC. | $237.44 | 2019-2024 | Denali Vena Cava Filter, Rotarexs 6 F X 135 Cm, Venovo |
| Trisalus Life Sciences, INC. | $232.86 | 2021-2023 | Trinav Infusion System |
| Cardiva Medical, INC. | $210.52 | 2022-2023 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Viz.Ai, INC. | $163.79 | 2022 | |
| Mediview Xr, INC. | $151.28 | 2025 | |
| Terumo Medical Corporation | $143.85 | 2025 | Azur Cx Detachable |
| Imperative Care, INC | $117.26 | 2025 | Symphony Catheter |
| Medtronic Vascular, INC. | $111.43 | 2019-2020 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $80.75 | 2019-2024 | Cook Celect, Cook |
| Biocompatibles, INC. | $79.27 | 2019 | |
| Ethicon US, LLC | $76.20 | 2020-2024 | Certus 140 |
| W. L. Gore & Associates, INC. | $68.50 | 2022-2023 | Gore Viabahn Vbx Balloon Expandable Endo |
| Biosense Webster, INC. | $54.99 | 2023-2024 | Nuvision Ice Catheter |
| Mozarc Medical US LLC | $51.73 | 2024-2025 | Palindrome, Chameleon |
| Merit Medical Systems INC | $41.52 | 2023-2024 | Proguide Chronic Dialysis Catheter, Centros Hemodialysis Catheter, Surfacer Inside-Out Catheter |
| Baylis Medical Technologies INC. | $35.90 | 2025 | |
| Depuy Synthes Sales INC. | $31.91 | 2023-2024 | Embotrap, Trufill, Emboguard |
| Medtronic USA, INC. | $29.39 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $20.88 | 2022 | |
| Angiodynamics, INC. | $20.79 | 2021 | |
| Janssen Pharmaceuticals, INC | $20.53 | 2022 | |
| Cardiovascular Systems INC. | $17.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,015.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Velling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.